Project wiki

Patient screening + follow-up

Working notes for one simple tool: registration screening, pathway follow-up, a liver registry, and later AI — from WhatsApp decisions and Max discharge summaries.

Summary

Start with the synthesis.

Sources so far

SourceWhat we learned
WhatsApp group AI follow-up vision; ~100 discharge summaries; screening tool; registry; liver diet/monitoring; DCLD meds list.
3 discharge summaries (Sep 2025) One LDLT family case: recipient + 2 living donors. Advice differs by pathway.
Guidelines check Salt / fluid / protein / rifaximin / carvedilol / PPI must be phenotype-specific.

Pages